OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
mRNA vaccines in the prevention and treatment of diseases
Yangzhuo Gu, Jiangyao Duan, Na Yang, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 33
Yangzhuo Gu, Jiangyao Duan, Na Yang, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 33
Showing 1-25 of 33 citing articles:
Recent Advancement in mRNA Vaccine Development and Applications
Nojoud AL Fayez, Majed S. Nassar, Abdullah A. Alshehri, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1972-1972
Open Access | Times Cited: 56
Nojoud AL Fayez, Majed S. Nassar, Abdullah A. Alshehri, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1972-1972
Open Access | Times Cited: 56
Strategies to reduce the risks of mRNA drug and vaccine toxicity
Dimitrios Bitounis, Eric Jacquinet, Maximillian A. Rogers, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 4, pp. 281-300
Closed Access | Times Cited: 52
Dimitrios Bitounis, Eric Jacquinet, Maximillian A. Rogers, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 4, pp. 281-300
Closed Access | Times Cited: 52
From structural design to delivery: mRNA therapeutics for cancer immunotherapy
Feng Zhou, Lujia Huang, Shiqin Li, et al.
Exploration (2023) Vol. 4, Iss. 2
Open Access | Times Cited: 43
Feng Zhou, Lujia Huang, Shiqin Li, et al.
Exploration (2023) Vol. 4, Iss. 2
Open Access | Times Cited: 43
Breaking the mold with RNA—a “RNAissance” of life science
Charles H. Jones, John R. Androsavich, N. So, et al.
npj Genomic Medicine (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 16
Charles H. Jones, John R. Androsavich, N. So, et al.
npj Genomic Medicine (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 16
Incorporation of a Toll-like receptor 2/6 agonist potentiates mRNA vaccines against cancer and infectious diseases
Yangzhuo Gu, H. J. Yang, Cai He, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 25
Yangzhuo Gu, H. J. Yang, Cai He, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 25
Lyophilization process optimization and molecular dynamics simulation of mRNA-LNPs for SARS-CoV-2 vaccine
Mingyuan Li, Lin Jia, Yanbo Xie, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 20
Mingyuan Li, Lin Jia, Yanbo Xie, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 20
Immunotherapy for Prostate Cancer: A Current Systematic Review and Patient Centric Perspectives
Laeeq ur Rehman, Muhammad Hassan Nisar, Wajeeha Fatima, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 4, pp. 1446-1446
Open Access | Times Cited: 19
Laeeq ur Rehman, Muhammad Hassan Nisar, Wajeeha Fatima, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 4, pp. 1446-1446
Open Access | Times Cited: 19
Advancing Therapeutic Strategies with Polymeric Drug Conjugates for Nucleic Acid Delivery and Treatment
Aftab Ullah, Marina Khan, Yibang Zhang, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 25-52
Open Access
Aftab Ullah, Marina Khan, Yibang Zhang, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 25-52
Open Access
Peptides: Potential Delivery Systems for mRNA
Huiting Liang, Yun Xing, Kai Wang, et al.
RSC Chemical Biology (2025)
Open Access
Huiting Liang, Yun Xing, Kai Wang, et al.
RSC Chemical Biology (2025)
Open Access
mRNA vaccine platforms: linking infectious disease prevention and cancer immunotherapy
Dariush Haghmorad, Majid Eslami, Niloufar Orooji, et al.
Frontiers in Bioengineering and Biotechnology (2025) Vol. 13
Open Access
Dariush Haghmorad, Majid Eslami, Niloufar Orooji, et al.
Frontiers in Bioengineering and Biotechnology (2025) Vol. 13
Open Access
Current Status and Challenges of Vaccination Therapy for Glioblastoma
Hamed Hosseinalizadeh, Mohammad Rahmati, Ammar Ebrahimi, et al.
Molecular Cancer Therapeutics (2023) Vol. 22, Iss. 4, pp. 435-446
Closed Access | Times Cited: 14
Hamed Hosseinalizadeh, Mohammad Rahmati, Ammar Ebrahimi, et al.
Molecular Cancer Therapeutics (2023) Vol. 22, Iss. 4, pp. 435-446
Closed Access | Times Cited: 14
mRNA vaccines: a new era in vaccine development
Shubhra Chandra, Jennifer C Wilson, David M. Good, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 10, pp. 1543-1564
Open Access | Times Cited: 4
Shubhra Chandra, Jennifer C Wilson, David M. Good, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 10, pp. 1543-1564
Open Access | Times Cited: 4
Engineered Cancer Nanovaccines: A New Frontier in Cancer Therapy
Yijie Wang, Congrui Liu, Chao Fang, et al.
Nano-Micro Letters (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 4
Yijie Wang, Congrui Liu, Chao Fang, et al.
Nano-Micro Letters (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 4
Advancements and challenges in mRNA and ribonucleoprotein-based therapies: From delivery systems to clinical applications
Zohre Eftekhari, Horieh Zohrabi, Akbar Oghalaie, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 3, pp. 102313-102313
Open Access | Times Cited: 3
Zohre Eftekhari, Horieh Zohrabi, Akbar Oghalaie, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 3, pp. 102313-102313
Open Access | Times Cited: 3
Delivery of nucleic acids using nanomaterials
Yuyang Qin, Liyuan Ou, Lili Zha, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 9
Yuyang Qin, Liyuan Ou, Lili Zha, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 9
Have mRNA vaccines sentenced DNA vaccines to death?
Alberto Cagigi, Bruno Douradinha
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 1154-1167
Open Access | Times Cited: 8
Alberto Cagigi, Bruno Douradinha
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 1154-1167
Open Access | Times Cited: 8
Polyethylene glycol modified protamine-chlorin e6 conjugate nanoparticles for enhanced cancer photodynamic therapy
Hang Hu, Ting Yuan, Jiahao Qian, et al.
European Polymer Journal (2024) Vol. 208, pp. 112871-112871
Closed Access | Times Cited: 2
Hang Hu, Ting Yuan, Jiahao Qian, et al.
European Polymer Journal (2024) Vol. 208, pp. 112871-112871
Closed Access | Times Cited: 2
A review for the prevention and management of Helicobacter pylori induced gastritis through development of novel vaccine candidates
Sanjib Das, Soumalya Banerjee, Prolay Halder, et al.
The Microbe (2024) Vol. 4, pp. 100114-100114
Open Access | Times Cited: 2
Sanjib Das, Soumalya Banerjee, Prolay Halder, et al.
The Microbe (2024) Vol. 4, pp. 100114-100114
Open Access | Times Cited: 2
Advancement in the development of DNA vaccines against Trypanosoma brucei and future perspective
Muhammad Tahir Aleem, Furqan Munir, Amna Shakoor, et al.
International Immunopharmacology (2024) Vol. 140, pp. 112847-112847
Closed Access | Times Cited: 2
Muhammad Tahir Aleem, Furqan Munir, Amna Shakoor, et al.
International Immunopharmacology (2024) Vol. 140, pp. 112847-112847
Closed Access | Times Cited: 2
Bioinformatics-Driven mRNA-Based Vaccine Design for Controlling Tinea Cruris Induced by Trichophyton rubrum
Amir Elalouf, Hanan Maoz, Amit Yaniv Rosenfeld
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 983-983
Open Access | Times Cited: 1
Amir Elalouf, Hanan Maoz, Amit Yaniv Rosenfeld
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 983-983
Open Access | Times Cited: 1
The transformative potential of mRNA vaccines for glioblastoma and human cancer: technological advances and translation to clinical trials
Iulia Tapescu, Peter J. Madsen, Pedro R. Löwenstein, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Iulia Tapescu, Peter J. Madsen, Pedro R. Löwenstein, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Synthetic nanomaterials for spleen-specific mRNA delivery
Shihong Nie, Beiqi Yang, Ruiying Ma, et al.
Biomaterials (2024) Vol. 314, pp. 122859-122859
Closed Access | Times Cited: 1
Shihong Nie, Beiqi Yang, Ruiying Ma, et al.
Biomaterials (2024) Vol. 314, pp. 122859-122859
Closed Access | Times Cited: 1
The Dawning of a New Enterprise: RNA Therapeutics for the Skin
Rachel E. Kieser, Shaheerah Khan, Nada Bejar, et al.
Journal of Dermatology and Skin Science (2023) Vol. 5, Iss. 1, pp. 4-13
Open Access | Times Cited: 3
Rachel E. Kieser, Shaheerah Khan, Nada Bejar, et al.
Journal of Dermatology and Skin Science (2023) Vol. 5, Iss. 1, pp. 4-13
Open Access | Times Cited: 3
Emerging perspectives on RNA virus-mediated infections: from pathogenesis to therapeutic interventions
Pratik Mohanty, Poojarani Panda, Rakesh Kumar Acharya, et al.
World Journal of Virology (2023) Vol. 12, Iss. 5, pp. 242-255
Open Access | Times Cited: 3
Pratik Mohanty, Poojarani Panda, Rakesh Kumar Acharya, et al.
World Journal of Virology (2023) Vol. 12, Iss. 5, pp. 242-255
Open Access | Times Cited: 3
